1 Taylor, T. H. et al. Outcomes of blastocysts biopsied and vitrified once versus those cryopreserved twice for euploid blastocyst transfer. Reproductive biomedicine online29, 59-64, doi:10.1016/j.rbmo.2014.03.001 (2014).
2 Roque, M., Valle, M., Guimarães, F., Sampaio, M. & Geber, S. Freeze-all policy: fresh vs. frozen-thawed embryo transfer. Fertil Steril103, 1190-1193, doi:10.1016/j.fertnstert.2015.01.045 (2015).
3 Maheshwari, A. et al. Is frozen embryo transfer better for mothers and babies? Can cumulative meta-analysis provide a definitive answer? Human reproduction update24, 35-58, doi:10.1093/humupd/dmx031 (2018).
4 Maheshwari, A., Raja, E. A. & Bhattacharya, S. Obstetric and perinatal outcomes after either fresh or thawed frozen embryo transfer: an analysis of 112,432 singleton pregnancies recorded in the Human Fertilisation and Embryology Authority anonymized dataset. Fertil Steril106, 1703-1708, doi:10.1016/j.fertnstert.2016.08.047 (2016).
5 Mackens, S. et al. Frozen embryo transfer: a review on the optimal endometrial preparation and timing. Hum Reprod32, 2234-2242, doi:10.1093/humrep/dex285 (2017).
6 Huang, P., Wei, L., Li, X. & Lin, Z. Modified hMG stimulated: an effective option in endometrial preparation for frozen-thawed embryo transfer in patients with normal menstrual cycles. Gynecol Endocrinol34, 772-774, doi:10.1080/09513590.2018.1460342 (2018).
7 Montagut, M. et al. Frozen-thawed embryo transfers in natural cycles with spontaneous or induced ovulation: the search for the best protocol continues. Hum Reprod31, 2803-2810, doi:10.1093/humrep/dew263 (2016).
8 Ozgur, K., Bulut, H., Berkkanoglu, M., Humaidan, P. & Coetzee, K. Artificial cryopreserved embryo transfer cycle success depends on blastocyst developmental rate and progesterone timing. Reproductive biomedicine online36, 269-276, doi:10.1016/j.rbmo.2017.12.009 (2018).
9 El-Toukhy, T. et al. Pituitary suppression in ultrasound-monitored frozen embryo replacement cycles. A randomised study. Hum Reprod19, 874-879 (2004).
10 Ramos, J. et al. Prospective randomized study to compare frozen-thawed embryo transfer cycles outcome in women with functioning ovaries and hrt for endometrium preparation with or without prior GnRHa suppression. 88, S114-S115 (2007).
11 Dal Prato, L. et al. Endometrial preparation for frozen-thawed embryo transfer with or without pretreatment with gonadotropin-releasing hormone agonist. Fertil Steril77, 956-960 (2002).
12 Azimi Nekoo, E. et al. Artificial Endometrial Preparation for Frozen-Thawed Embryo Transfer with or without Pretreatment with Depot Gonadotropin Releasing Hormone Agonist in Women with Regular Menses. J Family Reprod Health9, 1-4 (2015).
13 Simon, A., Hurwitz, A., Zentner, B. S., Bdolah, Y. & Laufer, N. Transfer of frozen-thawed embryos in artificially prepared cycles with and without prior gonadotrophin-releasing hormone agonist suppression: a prospective randomized study. Hum Reprod13, 2712-2717 (1998).
14 Groenewoud, E. R., Cantineau, A. E., Kollen, B. J., Macklon, N. S. & Cohlen, B. J. What is the optimal means of preparing the endometrium in frozen-thawed embryo transfer cycles? A systematic review and meta-analysis. Human reproduction update23, 255-261, doi:10.1093/humupd/dmw046 (2017).
15 Ghobara, T., Gelbaya, T. A. & Ayeleke, R. O. Cycle regimens for frozen-thawed embryo transfer. The Cochrane database of systematic reviews7, Cd003414, doi:10.1002/14651858.CD003414.pub3 (2017).
16 Lessey, B. A. Two pathways of progesterone action in the human endometrium: implications for implantation and contraception. Steroids68, 809-815, doi:10.1016/j.steroids.2003.09.004 (2003).
17 Lessey, B. A. Endometrial integrins and the establishment of uterine receptivity. Hum Reprod13 Suppl 3, 247-258; discussion 259-261, doi:10.1093/humrep/13.suppl_3.247 (1998).
18 Paulson, R. J. Hormonal induction of endometrial receptivity. Fertil Steril96, 530-535, doi:10.1016/j.fertnstert.2011.07.1097 (2011).
19 Chen, Q., Yu, F., Li, Y., Zhang, A. J. & Zhu, X. B. Comparative proteomics reveal negative effects of gonadotropin-releasing hormone agonist and antagonist on human endometrium. Drug design, development and therapy13, 1855-1863, doi:10.2147/dddt.S201871 (2019).
20 Lelaidier, C. et al. Controlled preparation of the endometrium with exogenous oestradiol and progesterone: a novel regimen not using a gonadotrophin-releasing hormone agonist. Hum Reprod7, 1353-1356, doi:10.1093/oxfordjournals.humrep.a137572 (1992).
21 Dong, M. et al. Gonadotropin-releasing hormone agonist combined with hormone replacement therapy does not improve the reproductive outcomes of frozen-thawed embryo transfer cycle in elderly patients: a retrospective study. Reproductive biology and endocrinology : RB&E18, 73, doi:10.1186/s12958-020-00626-8 (2020).
22 van de Vijver, A. et al. Cryopreserved embryo transfer in an artificial cycle: is GnRH agonist down-regulation necessary? Reproductive biomedicine online29, 588-594, doi:10.1016/j.rbmo.2014.08.005 (2014).
23 Keltz, M. D. et al. Baseline cyst formation after luteal phase gonadotropin-releasing hormone agonist administration is linked to poor in vitro fertilization outcome. Fertil Steril64, 568-572, doi:10.1016/s0015-0282(16)57794-2 (1995).
24 Leiva, R., Bouchard, T., Boehringer, H., Abulla, S. & Ecochard, R. Random serum progesterone threshold to confirm ovulation. Steroids101, 125-129, doi:10.1016/j.steroids.2015.06.013 (2015).
25 Zhao, J., Zhang, Q. & Li, Y. The effect of endometrial thickness and pattern measured by ultrasonography on pregnancy outcomes during IVF-ET cycles. Reproductive biology and endocrinology : RB&E10, 100, doi:10.1186/1477-7827-10-100 (2012).
26 Sallam, H. N., Garcia-Velasco, J. A., Dias, S. & Arici, A. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. The Cochrane database of systematic reviews, Cd004635, doi:10.1002/14651858.CD004635.pub2 (2006).
27 Surrey, E. S., Katz-Jaffe, M., Kondapalli, L. V., Gustofson, R. L. & Schoolcraft, W. B. GnRH agonist administration prior to embryo transfer in freeze-all cycles of patients with endometriosis or aberrant endometrial integrin expression. Reproductive biomedicine online35, 145-151, doi:10.1016/j.rbmo.2017.05.004 (2017).
28 Orvieto, R. et al. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity. Fertil Steril90, 1294-1296, doi:10.1016/j.fertnstert.2007.10.022 (2008).
29 Ruan, H. C. et al. Ovarian stimulation with GnRH agonist, but not GnRH antagonist, partially restores the expression of endometrial integrin beta3 and leukaemia-inhibitory factor and improves uterine receptivity in mice. Hum Reprod21, 2521-2529, doi:10.1093/humrep/del215 (2006).